Hallucination News and Research

RSS

A hallucination, in the broadest sense of the word, is a perception in the absence of a stimulus. In a stricter sense, hallucinations are defined as perceptions in a conscious and awake state in the absence of external stimuli which have qualities of real perception, in that they are vivid, substantial, and located in external objective space.

Link between Parkinson's and narcolepsy

Parkinson's disease is well-known for its progression of motor disorders: stiffness, slowness, tremors, difficulties walking and talking.

17 May 2007

Chemical maps hint at drug's effects on schizophrenia

Antipsychotic drugs do most of their work in the brain, but they also leave behind in the bloodstream a trail of hundreds of chemicals that may be used in the future to direct better treatment for schizophrenia and other psychiatric conditions, say Duke University Medical Center researchers.

16 May 2007

FDA approves skin patch designed to treat symptoms of early Parkinson's disease

Rotigotine is a drug not previously approved in the United States. Neupro is the first transdermal patch approved for the treatment of symptoms of Parkinson's disease.

10 May 2007

Bipolar all too often misdiagnosed

According to researchers from the National Institute of Mental Health (NIMH) there are twice as many Americans with bipolar disorder as previously thought, and many are untreated.

9 May 2007

Plant chemical harmine fights diabetes in mice

After screening hundreds of compounds for their effects on fat development, researchers have discovered that an ingredient found in some plants fights diabetes in mice without some of the side effects attributed to other antidiabetes drugs.

9 May 2007

INVEGA granted positive opinion recommending approval in Europe

Janssen-Cilag International NV has announced that the Committee for Human Medicinal Products (CHMP) in the European Union, has granted a positive opinion recommending approval of INVEGA (paliperidone prolonged release tablets).

30 Apr 2007

FDA approves INVEGA treatment for schizophrenia

The U.S. Food and Drug Administration (FDA) has approved INVEGA (paliperidone) Extended-Release Tablets, a new once-daily, atypical antipsychotic, for the long-term maintenance treatment of schizophrenia.

30 Apr 2007

Ropinirole reduces "off" time in Parkinson's

Parkinson disease patients taking the drug, ropinirole 24-hour prolonged release significantly reduced their daily "off" time in which Parkinson's symptoms like tremor, slowness, stiffness, and walking difficulty return as drugs wear off, according to a study published in the April 3, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.

4 Apr 2007

Warning about the indiscriminate use of diet drugs

The United Nations (UN) has issued a warning about the rise in a number of countries of the use of diet drugs to lose weight.

1 Mar 2007

Older schizophrenia drugs cheaper and work just as well

According to a new study an older antipsychotic drug has been found to be both cheaper and as effective for some patients with schizophrenia as the newer drugs on the market.

4 Dec 2006

Canada says warnings needed on bird flu drug Tamiflu

Canadian health authority Health Canada has requested that the manufacturer of the antiviral drug Tamiflu place warnings on it's labels of adverse effects.

1 Dec 2006

Tamiflu to carry warning about abnormal behaviour

The Food and Drug Administration in the U.S. (FDA) is recommending that patients who take Tamiflu be closely monitored for signs of abnormal behaviour.

14 Nov 2006

Symptoms of schizophrenia eased by music therapy

According to British researchers, some of the symptoms of schizophrenia may be eased with music therapy.

1 Nov 2006

Experts say "schizophrenia label" a harmful concept which should be dropped

British mental health experts say the term schizophrenia should abandoned as it has little scientific validity, and is imprecise and stigmatizing.

From The University of Manchester 10 Oct 2006

Unpleasant memories from intensive care

"Being cared for in an intensive care unit (ICU) can never be an especially positive experience. But at any rate it should not mean that the care improves the patient's physical condition only to leave him or her with severe mental problems!"

20 Sep 2006

Study compares delivery methods of schizophrenia medicines

More than half of schizophrenia patients don't take their medication as directed and a new study will determine whether biweekly physician visits and injectable drugs can change that.

12 Sep 2006

New aspect of prion disease - agent causes heart damage

Until now, prion disease has been thought of as a chronic neurological condition.

9 Jul 2006

Altered activity in receptor pair points to further complexity in schizophrenia pathology

Researchers at the University of Pennsylvania School of Medicine, in collaboration with scientists at the City University of New York, have identified a striking dysregulation in neuronal receptor activity in the postmortem brain tissue from patients with schizophrenia.

18 Jun 2006

Study identified characteristics of caregivers that may increase symptoms in dementia patients

Troublesome symptoms that accompany dementia - including wandering, hallucinations and restlessness - may increase if the patients' caregivers are young, less educated, over-burdened or depressed.

23 May 2006